High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: Prospects for an animal model of cutaneous gene therapy

Molecular Biotechnology

Volumn 34, Issue 2, 2006, Pages 239-245

  Peroni, Cibele Nunes ^a   Cecchi, Cláudia Regina ^a   Damiani, Renata ^a   Soares, Carlos R J ^a   Ribela, Maria Teresa C P ^a   Arkaten, Rosângela Do Rocio ^a   Bartolini, Paolo ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Circulatory half life; Cutaneous gene therapy; Growth hormone; High level secretion; Immunodeficient dwarf mice; Primary human keratinocytes; Retroviral vector; Transduced stem cells

Indexed keywords

BIOCHEMISTRY; CELLS; GENETIC ENGINEERING; GRAFTING (CHEMICAL); GROWTH KINETICS;

CIRCULATORY HALF-LIFE; CUTANEOUS GENE THERAPY; GROWTH HORMONES; HIGH-LEVEL SECRETION; IMMUNODEFICIENT DWARF MICE; PRIMARY HUMAN KERATINOCYTES; RETROVIRAL VECTOR; TRANSDUCED STEM CELLS;

HORMONES;

HUMAN GROWTH HORMONE; MOUSE GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY WEIGHT; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; EX VIVO GENE TRANSFER; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; SCID MOUSE; VIRAL GENE THERAPY;

ANIMALIA;

EID: 33845915283     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:34:2:239     Document Type: Conference Paper

References (44)

1. Peroni, C. N., Gout, P. W., and Bartolini, P. (2005) Animal models for growth hormone gene therapy. Curr. Gene Ther. 5, 493-509.
2. Rosenberg, S. A., Aebersold, P., Cornetta, K., et al. (1990) Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323, 570-578.
3. Edelstein, M. L., Abedi, M. R., Wixon, J., and Edelstein, R. M. (2004) Gene therapy clinical trials worldwide 1989-2004: an overview. J. Gene Med. 6, 597-602.
4. -) SCID - initial trials results after 4 years. Science 270, 475-480.
5. Cavazzana-Calvo, M., Thrasher, A., and Mavilio, F. (2004) The future of gene therapy. Nature 427, 779-781.
6. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
7. Aiuti, A., Vai, S., Mortellaro, A., et al. (2002) Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat. Med. 8, 423-425.
8. Aiuti, A., Slavin, S., Aker, M., et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
9. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
10. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
11. Raper, S. E., Chirmule, N., Lee, F. S., et al. (2003) Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148-158.
12. Morgan, R. A. and Anderson, W. F. (1993) Human gene therapy. Annu. Rev. Biochem. 62, 191-217.
13. Heartlein, M. W., Roman, V. A., Jiang, J., et al. (1994) Long-term production and delivery of human growth hormone in vivo. Proc. Natl. Acad. Sci. USA 91, 10,967-10,971.
14. He, X., Goldsmith, C. M., Marmary, Y., et al. (1998) Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther. 5, 537-541.
15. Bellini, M. H., Peroni, C. N., and Bartolini P. (2003) Increases in weight of growth hormone-deficient and immunodeficient (lit/scid) dwarf mice after grafting of hGH-secreting, primary human keratinocytes. FASEB J. 17, 2322-2324.
16. Nathwani, A. C., Davidoff, A. M., and Linch, D. C. (2004) A review of gene therapy for haematological disorders. B. J. Haematol. 128, 3-17.
17. Roth, D. A., Tawa, N. E., O'Brien, J. M., Treco, D. A., and Selden, R. F. (2001) Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N. Engl. J. Med. 344, 1735-1742.
18. Chuah, M. K. L., Collen, D., and VandenDriessche, T. (2004) Clinical gene transfer studies for hemophilia A. Semin.Thromb. Hemost. 30, 249-256.
19. Dellambra, E., Vailly, J., Pellegrini, G., et al. (1998) Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum. Gene Ther. 9, 1359-1370.
20. Dellambra, E., Pellegrini, G., Guerra, L., et al. (2000) Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa. Hum. Gene Ther. 11, 2283-2287.
21. Hengge, U. R. (2005) Progress and prospects of skin gene therapy: a ten year history. Clin. Dermatol. 23, 107-114.
22. Ferrari, S., Pellegrini, G., Mavilio, F., and De Luca, M. (2005) Gene therapy for epidermolysis bullosa. Clin. Dermatol. 23, 430-436.
23. Rheinwald, J. G. and Green, H. (1975) Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 6, 317-330.
24. O'Connor, N. E., Mulliken, J. B., Banks-Schlegel, S., Kehinde, O., and Green, H. (1981) Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1, 75-78.
25. De Luca, M., Albanese, E., Bondanza, S., et al. (1989) Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 15, 303-309.
26. Pellegrini, G., Bondanza, S., Guerra, L., and De Luca, M. (1998) Cultivation of human keratinocyte stem cells: current and future clinical applications. Med. Biol. Eng. Comput. 36, 778-790.
27. Pfutzner, W. and Vogel, J. C. (2000) Advances in skin gene therapy. Exp. Opin. Invest. Drugs 9, 2069-2083.
28. Cao, T., Wang, X., and Roop, D. R. (2000) Regulated cutaneous gene delivery: the skin as a bioreactor. Hum. Gene Ther. 11, 2297-2300.
29. Taichman, L. B. (1999) Systemic replacement therapy from genetically modified epidermal keratinocytes. Proc. Assoc. Am. Physicians 111, 206-210.
30. Krueger, G. G., Jorgensen, C. M., Matsunami, N., et al. (1999) Persistent transgene expression and normal differentiation of immortalized human keratinocytes in vivo. J. Invest. Dermatol. 112, 233-239.
31. Morgan, J. R., Barrandon, Y., Green, H., and Mulligan, R. C. (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476-1479.
32. Teumer, J., Lindahl, A., and Green, H. (1990) Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB J. 4, 3245-3250.
33. Rheinwald, J. G. and Beckett, M. A. (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41, 1657-1663.
34. Jensen, U. B., Jensen, T. G., Jensen, P. K. A., et al. (1994) Gene transfer into culture human epidermis and its transplantation onto immunodeficient mice: an experimental model for somatic gene therapy. J. Invest. Dermatol. 103, 391-394.
35. Vogt, P. M., Thompson, S., Andree, C., et al. (1994) Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc. Natl. Acad. Sci. USA 91, 9307-9311.
36. Miller, A. D. and Rosman, G. J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
37. Barrandon, Y., Li, V., and Green, H. (1988) New techniques for the grafting of cultured human epidermal cells onto athymic animals. J. Invest. Dermatol. 91, 315-318.
38. Garlick, J. A. and Taichman, L. B. (1994) Effect of TGF-β1 on re-epithelization of human keratinocytes in vitro: an organotypic model. J. Invest. Dermatol. 103, 554-559.
39. Kolodka, T. M., Garlick, J. A., and Taichman, L. B. (1998) Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc. Natl. Acad. Sci. USA 95, 4356-4361.
40. Dunnwald, M., Tomaneck-Chalkley, A., Alexandrunas, D., Fishbaugh, J., and Bickenbach, J. R. (2001) Isolating a pure population of epidermal stem cells for use in tissue engineering. Exp. Dermatol. 10, 45-54.
41. Bajaj, B. G., Lei, P., and Andreadis, S. T. (2005) Efficient gene transfer to human epidermal keratinocytes on fibronectin: in vitro evidence for transduction of epidermal stem cells. Mol. Ther. 11, 969-979.
42. Mathor, M. B., Ferrari, G., Dellambra, E., et al. (1996) Clonal analysis of stably transduced human epidermal stem cells in culture. Proc. Natl. Acad. Sci. USA 93, 10,371-10,376.
43. Gerrard, A. J., Hudson, D. L., Brownlee, G. G., and Watt, F. M. (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet. 3, 180-183.
44. Hahn, T. M., Copeland, K. C., and Woo, S. L. C. (1996) Phenotypic correction of dwarfism by constitutive expression of growth hormone. Endocrinology 137, 4988-4993.